Comment: Re:THIS IS NOT NEWS (Score 5, Informative) 182
The Harvard researchers didn't use gene therapy to lengthen the telomeres. They engineered a knock-in allele encoding a 4-hydroxytamoxifen (4-OHT)-inducible telomerase reverse transcriptase-Estrogen Receptor (TERT-ER) under transcriptional control of the endogenous TERT promoter. Basically, the mice had short telomeres and the researchers could reactivate telomerase by administering 4-OHT. That's genetic engineering, not gene therapy in adult mice.
Furthermore, the Harvard researchers showed the reversal of artificially-induced aging, but not an increase in lifespan. The researchers in this study demonstrated an increase in lifespan in normal mice.
The Harvard study showed that improving telomerase activity could reverse or slow aging, but it didn't show how to actually accomplish this in normal, adult organisms. That's what the researchers in this study have done, at least in mice.